This book is a practical guide to the use of modern radiation therapy techniques in women with gynecological cancers. Step-by-step instruction is provided on simulation, contouring, and treatment planning and delivery for cancers of the cervix, endometrium, vagina, and vulva. Beyond external beam radiation delivery, full details are presented on three-dimensional brachytherapy at all sites for which it is applicable. Moreover, in-depth guidance is offered on the various advanced techniques of radiation delivery, including intensity-modulated radiation therapy, image guidance for external beam and brachytherapy, and stereotactic body radiotherapy. Radiation therapy is a critical component of the multidisciplinary management of gynecological tumors. With modern technology, both external beam radiation and brachytherapy can be delivered in a highly conformal way. This requires precise contouring and accurate planning techniques. In clearly describing the indications for and the delivery of quality radiation therapy for gynecological tumors, this book will benefit radiation oncologists, medical physicists, medical dosimetrists, radiation therapists, and radiotherapy residents.

"Atlas of Staging in Gynecological Cancer" is designed to be used in conjunction with diagnostic procedures between the surgeon and the radiologist. It describes the two common staging regimes used by all units across the world, namely, the FIGO staging system and the TNM system. The ‘landscape’ format allows each chapter to open on the left hand side and read across the double spread, enabling the reader to see both staging systems at once. Each chapter has a separate section on Epidemiology, Diagnosis, with radiological plates, Management, in tabular form, and Key Points.

Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings.

****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Female Genital Tumours is the fourth volume in the 5th edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The 5th edition, guided by the WHO Classification of Tumours Editorial Board, will establish a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? - Pathologists - Oncologists - Cancer researchers - Surgeons - Epidemiologists - Cancer registrars This volume - Prepared by 191 authors and editors - Contributors from around the world - More than 850 high-quality images - More than 3100 references

This brand-new reference provides multidisciplinary guidance on the biology, diagnosis, treatment, and supportive care of patients with cancers of the female reproductive tract. An international group of experts present sections on management controversies, complications of cancer treatment, surgical techniques, symptom management, and more.

The most readable, most comprehensive book in its field, Clinical Gynecologic Oncology, 9th Edition is the leading reference for diagnosis and treatment of gynecologic cancers – a must-have reference for improving outcomes and providing effective care. A "who’s who" list of contributing authors, under the editorial direction of Drs. Philip DiSaia and William Creasman, provides expert guidance on clinical presentations and management, now fully up to date with a brand-new design for faster, easier reference. Contains useful appendices covering staging, screening, nutritional therapy, toxicity criteria, blood component therapy, and radiation therapy. Covers hot topics such as multi-panel genetic testing, target therapies, sentinel node concept in endometrial cancer and vulvar cancer, and robotic surgery. Updates include new quick-reference features such as key point boxes with bulleted lists, highlighted key text, enhanced chapter outlines, and a brand-new design throughout. Includes up-to-date references and algorithms, making this text a comprehensive resource for clinical practice, personal study, and exam review. Helps you take advantage of the latest advances in early detection and improved treatment options for gynecologic cancers, especially uterine and cervical cancers.

This book was written for the complex scenario of fertility-sparing management in gynaecological cancer. In reproductive age women, appropriate counselling is mandatory in any cancer diagnosis, including discussing the long-term consequences of the different treatment options on fertility and the possibility of fertility preservation. However, women affected by gynaecological cancer must consider that treatment options including hysterectomy and bilateral oophorectomy in most cases. Therefore, in gynaecological cancer, the standard treatment often consists of an inevitable loss of fertility. The direct consequence is that fertility preservation management does not always result in the optimal treatment of the disease, which increases the risk of worsening oncologic outcomes. This book discusses all the elements involved in managing these patients to provide a complete and detailed overview of fertility preservation management options in young women affected by gynaecological cancers. Specifically, this book discusses the role of genetic assessment and counselling, the effect of anticancer treatments for gynaecological cancer on fertility, classic fertility preservation techniques adapted to gynaecological cancer, detailed and specific fertility preservation management for cervical, ovarian, and endometrial cancer, and the role of a multidisciplinary approach in these patients.